fluoxetine has been researched along with Skin Diseases in 7 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The adverse event profile in obese patients, though differing slightly from that seen in depressed patients, was similar in that events observed were generally mild and well tolerated." | 5.27 | Safety of fluoxetine in the treatment of obesity. ( Zerbe, RL, 1987) |
| " The adverse event profile in obese patients, though differing slightly from that seen in depressed patients, was similar in that events observed were generally mild and well tolerated." | 1.27 | Safety of fluoxetine in the treatment of obesity. ( Zerbe, RL, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Krooks, JA | 1 |
| Weatherall, AG | 1 |
| Holland, PJ | 1 |
| Sharma, H | 1 |
| Van De Kerkhof, PC | 1 |
| Crowson, AN | 1 |
| Magro, CM | 1 |
| Gupta, MA | 1 |
| Gupta, AK | 1 |
| Carli, P | 1 |
| Gisserot, O | 1 |
| Marlier, S | 1 |
| Paris, JF | 1 |
| Zerbe, RL | 1 |
1 review available for fluoxetine and Skin Diseases
| Article | Year |
|---|---|
Review of epidemiology, clinical presentation, diagnosis, and treatment of common primary psychiatric causes of cutaneous disease.
Topics: Antipsychotic Agents; Body Dysmorphic Disorders; Cognitive Behavioral Therapy; Fluoxetine; Humans; M | 2018 |
6 other studies available for fluoxetine and Skin Diseases
| Article | Year |
|---|---|
Psychogenic excoriation responding to fluoxetine: a case report.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Behavior Therapy; Clomipramine; Compulsive Beh | 2008 |
Drug induced aggravation of chronic skin diseases.
Topics: Chronic Disease; Dermatitis, Exfoliative; Drug Eruptions; Fluoxetine; Follow-Up Studies; Humans; Pso | 2009 |
Antidepressant therapy. A possible cause of atypical cutaneous lymphoid hyperplasia.
Topics: Adult; Aged; Amitriptyline; Drug Eruptions; Female; Fluoxetine; Humans; Leukemia, Lymphocytic, Chron | 1995 |
Fluoxetine is an effective treatment for neurotic excoriations: case report.
Topics: Adolescent; Female; Fluoxetine; Humans; Self-Injurious Behavior; Skin Diseases | 1993 |
[Exasperating hematomas].
Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Second-Generation; Depression; Female; Fl | 1999 |
Safety of fluoxetine in the treatment of obesity.
Topics: Drug Interactions; Fluoxetine; Heart; Humans; Lipidoses; Liver; Obesity; Phospholipids; Propylamines | 1987 |